Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2021 Filed May 17, 2021 20:46 UTC |
ZECCHINI EDWARD JDirector
|
SaleCommon Stock | 1,694 | $52.09 | $88,237.07 |
DisclosureSEC source: 0001104659-21-068201 · tm2116712-1_4.xml · nonDerivative · entry 3 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,023 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.73 to $52.63, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| May 13, 2021 Filed May 17, 2021 20:46 UTC |
ZECCHINI EDWARD JDirector
|
SaleCommon Stock | 3,723 | $51.23 | $190,746.79 |
DisclosureSEC source: 0001104659-21-068201 · tm2116712-1_4.xml · nonDerivative · entry 2 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,717 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.73 to $51.72, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| May 13, 2021 Filed May 17, 2021 20:46 UTC |
ZECCHINI EDWARD JDirector
|
Exercise / conversionCommon Stock | 5,417 | $4.80 | $26,001.60 |
DisclosureSEC source: 0001104659-21-068201 · tm2116712-1_4.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. Read SEC document |
| April 30, 2021 Filed May 7, 2021 18:42 UTC |
BERMAN RICHARD JDirector
|
GrantRestricted Stock Rights · Derivative | 2,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-063249 · tm2115610d2_4.xml · derivative · entry 2 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,708 Underlying: Common Stock · 2,708 shares Expires 2022-04-30 F2 · derivative.exercise_price: Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| April 30, 2021 Filed May 7, 2021 18:42 UTC |
BERMAN RICHARD JDirector
|
GrantOption to purchase common stock · Derivative | 5,416 | $0.00 Strike: $56.57 | $0.00 |
DisclosureSEC source: 0001104659-21-063249 · tm2115610d2_4.xml · derivative · entry 1 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,416 Underlying: Common Stock · 5,416 shares Expires 2028-04-30 F1 · derivative.exercise_date: 1/12th of options vest on the 30th of the month for twelve months beginning May 30, 2021. Read SEC document |
| April 30, 2021 Filed May 7, 2021 22:44 UTC |
ZECCHINI EDWARD JDirector
|
GrantRestricted Stock Rights · Derivative | 2,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-063253 · tm2115610d6_4.xml · derivative · entry 2 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,708 Underlying: Common Stock · 2,708 shares Expires 2022-04-30 F2 · derivative.exercise_price: Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| April 30, 2021 Filed May 7, 2021 22:44 UTC |
ZECCHINI EDWARD JDirector
|
GrantOption to purchase common stock · Derivative | 5,416 | $0.00 Strike: $56.57 | $0.00 |
DisclosureSEC source: 0001104659-21-063253 · tm2115610d6_4.xml · derivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,416 Underlying: Common Stock · 5,416 shares Expires 2028-04-30 F1 · derivative.exercise_date: 1/12th of options vest on the 30th of the month for twelve months beginning May 30, 2021. Read SEC document |
| April 30, 2021 Filed May 7, 2021 22:43 UTC |
Mandalam RamkumarDirector
|
GrantRestricted Stock Rights · Derivative | 2,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-063252 · tm2115610d5_4.xml · derivative · entry 2 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,708 Underlying: Common Stock · 2,708 shares Expires 2022-04-30 F2 · derivative.exercise_price: Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| April 30, 2021 Filed May 7, 2021 22:43 UTC |
Mandalam RamkumarDirector
|
GrantOption to purchase common stock · Derivative | 5,416 | $0.00 Strike: $56.57 | $0.00 |
DisclosureSEC source: 0001104659-21-063252 · tm2115610d5_4.xml · derivative · entry 1 Mandalam Ramkumar · CIK 0001611439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,416 Underlying: Common Stock · 5,416 shares Expires 2028-04-30 F1 · derivative.exercise_date: 1/12th of options vest on the 30th of the month for twelve months beginning May 30, 2021. Read SEC document |
| April 30, 2021 Filed May 7, 2021 22:42 UTC |
Hariri Robert JDirector
|
GrantRestricted Stock Rights · Derivative | 2,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-063251 · tm2115610d4_4.xml · derivative · entry 2 Hariri Robert J · CIK 0001398815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,708 Underlying: Common Stock · 2,708 shares Expires 2022-04-30 F2 · derivative.exercise_price: Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| April 30, 2021 Filed May 7, 2021 22:42 UTC |
Hariri Robert JDirector
|
GrantOption to purchase common stock · Derivative | 5,416 | $0.00 Strike: $56.57 | $0.00 |
DisclosureSEC source: 0001104659-21-063251 · tm2115610d4_4.xml · derivative · entry 1 Hariri Robert J · CIK 0001398815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,416 Underlying: Common Stock · 5,416 shares Expires 2028-04-30 F1 · derivative.exercise_date: 1/12th of options vest on the 30th of the month for twelve months beginning May 30, 2021. Read SEC document |
| April 30, 2021 Filed May 7, 2021 22:42 UTC |
HANCOCK DANIEL MDirector
|
GrantRestricted Stock Rights · Derivative | 2,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-063250 · tm2115610d3_4.xml · derivative · entry 2 HANCOCK DANIEL M · CIK 0001764017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,708 Underlying: Common Stock · 2,708 shares Expires 2022-04-30 F2 · derivative.exercise_price: Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| April 30, 2021 Filed May 7, 2021 22:42 UTC |
HANCOCK DANIEL MDirector
|
GrantOption to purchase common stock · Derivative | 5,416 | $0.00 Strike: $56.57 | $0.00 |
DisclosureSEC source: 0001104659-21-063250 · tm2115610d3_4.xml · derivative · entry 1 HANCOCK DANIEL M · CIK 0001764017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,416 Underlying: Common Stock · 5,416 shares Expires 2028-04-30 F1 · derivative.exercise_date: 1/12th of options vest on the 30th of the month for twelve months beginning May 30, 2021. Read SEC document |
| April 30, 2021 Filed May 7, 2021 22:41 UTC |
BADDOUR LINDADirector
|
GrantRestricted Stock Rights · Derivative | 2,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-063248 · tm2115610d1_4.xml · derivative · entry 2 BADDOUR LINDA · CIK 0001181151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,708 Underlying: Common Stock · 2,708 shares Expires 2022-04-30 F2 · derivative.exercise_price: Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| April 30, 2021 Filed May 7, 2021 22:41 UTC |
BADDOUR LINDADirector
|
GrantOption to purchase common stock · Derivative | 5,416 | $0.00 Strike: $56.57 | $0.00 |
DisclosureSEC source: 0001104659-21-063248 · tm2115610d1_4.xml · derivative · entry 1 BADDOUR LINDA · CIK 0001181151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,416 Underlying: Common Stock · 5,416 shares Expires 2028-04-30 F1 · derivative.exercise_date: 1/12th of options vest on the 30th of the month for twelve months beginning May 30, 2021. Read SEC document |
| April 29, 2021 Filed May 24, 2021 22:00 UTC |
BADDOUR LINDADirector
|
Exercise / conversionRestricted Stock Rights · Derivative | 341 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-071380 · tm2117431d1_4.xml · derivative · entry 2 BADDOUR LINDA · CIK 0001181151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 341 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Rights convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On March 15, 2021, the reporting person was grated 341 Restricted Stock Rights that vested on April 29, 2021. F2 · derivative.expiration_date: On March 15, 2021, the reporting person was grated 341 Restricted Stock Rights that vested on April 29, 2021. Read SEC document |
| April 29, 2021 Filed May 24, 2021 22:00 UTC |
BADDOUR LINDADirector
|
Exercise / conversionCommon Stock | 341 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-071380 · tm2117431d1_4.xml · nonDerivative · entry 1 BADDOUR LINDA · CIK 0001181151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Rights convert into common stock on a one-for-one basis. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 23:24 UTC |
ZECCHINI EDWARD JDirector
|
Exercise / conversionOption to purchase common stock · Derivative | 5,417 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001104659-21-048986 · tm2112685-2_4seq1.xml · derivative · entry 4 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,417 Underlying: Common Stock · 5,417 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F4 · derivative.exercise_date: 1/48th of the options vested on the 18th day of each month for the forty-eight months beginning on 1/18/2015. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 23:24 UTC |
ZECCHINI EDWARD JDirector
|
SaleCommon Stock | 3,117 | $52.30 | $163,026.58 |
DisclosureSEC source: 0001104659-21-048986 · tm2112685-2_4seq1.xml · nonDerivative · entry 3 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.04 to $52.4997, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3 to this Form 4. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 23:24 UTC |
ZECCHINI EDWARD JDirector
|
SaleCommon Stock | 2,300 | $51.81 | $119,153.11 |
DisclosureSEC source: 0001104659-21-048986 · tm2112685-2_4seq1.xml · nonDerivative · entry 2 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,117 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.23 to $51.96, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 23:24 UTC |
ZECCHINI EDWARD JDirector
|
Exercise / conversionCommon Stock | 5,417 | $4.80 | $26,001.60 |
DisclosureSEC source: 0001104659-21-048986 · tm2112685-2_4seq1.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 19:23 UTC |
BERMAN RICHARD JDirector
|
Exercise / conversionOptions to purchase common stock · Derivative | 6,923 | $0.00 Strike: $9.29 | $0.00 |
DisclosureSEC source: 0001104659-21-048985 · tm2112685-1_4seq1.xml · derivative · entry 4 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,923 shares Expires 2028-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/12th of the 35,000 options originally granted vested on the 17th of the month for twelve months beginning on June 17, 2018. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 19:23 UTC |
BERMAN RICHARD JDirector
|
Exercise / conversionOptions to purchase common stock · Derivative | 20,866 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001104659-21-048985 · tm2112685-1_4seq1.xml · derivative · entry 3 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,134 Underlying: Common Stock · 20,866 shares Expires 2029-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/12th of the 35,000 options originally granted vested on the 2nd of the month for twelve months beginning on June 2, 2019. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 19:23 UTC |
BERMAN RICHARD JDirector
|
Exercise / conversionCommon Stock | 20,866 | $14.35 | $299,427.10 |
DisclosureSEC source: 0001104659-21-048985 · tm2112685-1_4seq1.xml · nonDerivative · entry 2 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 19:23 UTC |
BERMAN RICHARD JDirector
|
Exercise / conversionCommon Stock | 6,923 | $9.29 | $64,314.67 |
DisclosureSEC source: 0001104659-21-048985 · tm2112685-1_4seq1.xml · nonDerivative · entry 1 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 20:46 UTC |
HANCOCK DANIEL MDirector
|
GrantCommon Stock | 229 | $50.24 | $11,504.96 |
DisclosureSEC source: 0001104659-21-046126 · tm2111959d1_form4.xml · nonDerivative · entry 1 HANCOCK DANIEL M · CIK 0001764017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,627 Read SEC document |
| March 24, 2021 Filed Mar 25, 2021 16:47 UTC |
BERMAN RICHARD JDirector
|
Exercise / conversionOptions to purchase common stock · Derivative | 28,077 | $0.00 Strike: $9.29 | $0.00 |
DisclosureSEC source: 0001104659-21-041552 · tm2110964d1_4.xml · derivative · entry 6 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,923 Underlying: Common Stock · 28,077 shares Expires 2028-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/12 of the 35,000 options originally granted vested on the 17th of the month for twelve months beginning on June 17, 2018. Read SEC document |
| March 24, 2021 Filed Mar 25, 2021 16:47 UTC |
BERMAN RICHARD JDirector
|
Exercise / conversionOptions to purchase common stock · Derivative | 18,885 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001104659-21-041552 · tm2110964d1_4.xml · derivative · entry 5 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,115 shares Expires 2027-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/12 of the 35,000 options originally granted vested on the 23rd of the month for twelve months beginning on July 23, 2017. Read SEC document |
| March 24, 2021 Filed Mar 25, 2021 16:47 UTC |
BERMAN RICHARD JDirector
|
Exercise / conversionOptions to purchase common stock · Derivative | 4,167 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001104659-21-041552 · tm2110964d1_4.xml · derivative · entry 4 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,167 shares Expires 2025-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/12 of the 50,000 options originally granted vested on the 12th of the month for twelve months beginning on June 7, 2015. Read SEC document |
| March 24, 2021 Filed Mar 25, 2021 16:47 UTC |
BERMAN RICHARD JDirector
|
Exercise / conversionCommon Stock | 28,077 | $9.29 | $260,835.33 |
DisclosureSEC source: 0001104659-21-041552 · tm2110964d1_4.xml · nonDerivative · entry 3 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,211 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2021 Filed Mar 25, 2021 16:47 UTC |
BERMAN RICHARD JDirector
|
Exercise / conversionCommon Stock | 18,885 | $4.80 | $90,648.00 |
DisclosureSEC source: 0001104659-21-041552 · tm2110964d1_4.xml · nonDerivative · entry 2 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2021 Filed Mar 25, 2021 16:47 UTC |
BERMAN RICHARD JDirector
|
Exercise / conversionCommon Stock | 4,167 | $7.80 | $32,502.60 |
DisclosureSEC source: 0001104659-21-041552 · tm2110964d1_4.xml · nonDerivative · entry 1 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:56 UTC |
BADDOUR LINDADirector
|
GrantRestricted Stock Rights · Derivative | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-037756 · tm2110061d2_form4.xml · derivative · entry 4 BADDOUR LINDA · CIK 0001181151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,333 Underlying: Common Stock · 3,333 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F4 · derivative.exercise_date: The restricted stock rights vest in three equal annual installments beginning March 15, 2022. F4 · derivative.expiration_date: The restricted stock rights vest in three equal annual installments beginning March 15, 2022. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:56 UTC |
BADDOUR LINDADirector
|
GrantRestricted Stock Rights · Derivative | 341 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-037756 · tm2110061d2_form4.xml · derivative · entry 3 BADDOUR LINDA · CIK 0001181151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341 Underlying: Common Stock · 341 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F3 · derivative.exercise_date: The restricted stock rights vest on April 29, 2021. F3 · derivative.expiration_date: The restricted stock rights vest on April 29, 2021. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:56 UTC |
BADDOUR LINDADirector
|
GrantOption to purchase common stock · Derivative | 683 | $0.00 Strike: $57.87 | $0.00 |
DisclosureSEC source: 0001104659-21-037756 · tm2110061d2_form4.xml · derivative · entry 2 BADDOUR LINDA · CIK 0001181151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 683 Underlying: Common Stock · 683 shares Expires 2028-03-15 F2 · derivative.exercise_date: 228 options vest on March 30, 2021. The remaining 455 options vest on April 29, 2021. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:56 UTC |
BADDOUR LINDADirector
|
GrantOption to purchase common stock · Derivative | 6,667 | $0.00 Strike: $57.87 | $0.00 |
DisclosureSEC source: 0001104659-21-037756 · tm2110061d2_form4.xml · derivative · entry 1 BADDOUR LINDA · CIK 0001181151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 Underlying: Common Stock · 6,667 shares Expires 2028-03-15 F1 · derivative.exercise_date: 1/36th of options vest on the 15th of the month for thirty-six months beginning April 15, 2021. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 23:33 UTC |
ZECCHINI EDWARD JDirector
|
Exercise / conversionOption to purchase common stock · Derivative | 4,167 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001104659-21-035739 · tm219635d1_4.xml · derivative · entry 3 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,167 shares Expires 2024-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F3 · derivative.exercise_date: 1/12 of the options vested on the 24th day of each month for the twelve months beginning on 9/29/2014. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 23:33 UTC |
ZECCHINI EDWARD JDirector
|
SaleCommon Stock | 4,167 | $55.65 | $231,886.88 |
DisclosureSEC source: 0001104659-21-035739 · tm219635d1_4.xml · nonDerivative · entry 2 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,023 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.14 to $55.88, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 23:33 UTC |
ZECCHINI EDWARD JDirector
|
Exercise / conversionCommon Stock | 4,167 | $5.04 | $21,001.68 |
DisclosureSEC source: 0001104659-21-035739 · tm219635d1_4.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 02:09 UTC |
Sawicki Mark WChief Scientific Officer
|
Exercise / conversionOptions to purchase common stock · Derivative | 7,231 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001104659-21-035159 · tm219529d2_4seq1.xml · derivative · entry 10 Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,231 shares Expires 2026-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 1/48th of the 70,000 options originally granted vested on the 6th of each month for forty-eight months beginning June 6, 2016. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 02:09 UTC |
Sawicki Mark WChief Scientific Officer
|
Exercise / conversionOptions to purchase common stock · Derivative | 11,831 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0001104659-21-035159 · tm219529d2_4seq1.xml · derivative · entry 9 Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,831 shares Expires 2021-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 1/48th of the 78,000 options originally granted vested on the 18th of each month for forty-eight months beginning June 18, 2017. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 02:09 UTC |
Sawicki Mark WChief Scientific Officer
|
Exercise / conversionOptions to purchase common stock · Derivative | 11,342 | $0.00 Strike: $3.07 | $0.00 |
DisclosureSEC source: 0001104659-21-035159 · tm219529d2_4seq1.xml · derivative · entry 8 Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,342 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 1/48th of the 77,625 options originally granted vested on the 7th of each month for forty-eight months beginning June 7, 2015. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 02:09 UTC |
Sawicki Mark WChief Scientific Officer
|
SaleCommon Stock | 9,357 | $55.33 | $517,767.72 |
DisclosureSEC source: 0001104659-21-035159 · tm219529d2_4seq1.xml · nonDerivative · entry 5 Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,073 Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 02:09 UTC |
Sawicki Mark WChief Scientific Officer
|
SaleCommon Stock | 3,974 | $54.65 | $217,166.38 |
DisclosureSEC source: 0001104659-21-035159 · tm219529d2_4seq1.xml · nonDerivative · entry 4 Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,430 Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 02:09 UTC |
Sawicki Mark WChief Scientific Officer
|
Exercise / conversionCommon Stock | 11,831 | $3.21 | $37,977.51 |
DisclosureSEC source: 0001104659-21-035159 · tm219529d2_4seq1.xml · nonDerivative · entry 3 Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 02:09 UTC |
Sawicki Mark WChief Scientific Officer
|
Exercise / conversionCommon Stock | 7,231 | $1.87 | $13,521.97 |
DisclosureSEC source: 0001104659-21-035159 · tm219529d2_4seq1.xml · nonDerivative · entry 2 Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 02:09 UTC |
Sawicki Mark WChief Scientific Officer
|
Exercise / conversionCommon Stock | 11,342 | $3.07 | $34,819.94 |
DisclosureSEC source: 0001104659-21-035159 · tm219529d2_4seq1.xml · nonDerivative · entry 1 Sawicki Mark W · CIK 0001848218 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 12, 2021 02:09 UTC |
STEFANOVICH ROBERTChief Financial Officer
|
GrantRestricted Stock Rights · Derivative | 10,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-035160 · tm219529d3_4seq1.xml · derivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,667 Underlying: Common Stock · 10,667 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F3 · derivative.exercise_date: The restricted stock rights vest in four equal annual installments beginning 3/9/2022. F3 · derivative.expiration_date: The restricted stock rights vest in four equal annual installments beginning 3/9/2022. Read SEC document |
| March 09, 2021 Filed Mar 12, 2021 02:09 UTC |
STEFANOVICH ROBERTChief Financial Officer
|
GrantOption to purchase common stock · Derivative | 21,333 | $0.00 Strike: $58.94 | $0.00 |
DisclosureSEC source: 0001104659-21-035160 · tm219529d3_4seq1.xml · derivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,333 Underlying: Common Stock · 21,333 shares Expires 2028-03-09 F1 · derivative.exercise_date: 1/48 of options vest on the 9th of each month for forty-eight months beginning 4/09/2021. Read SEC document |
| March 09, 2021 Filed Mar 12, 2021 02:08 UTC |
SHELTON JERRELLDirector · Chief Executive Officer
|
GrantRestricted Stock Rights · Derivative | 33,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-035157 · tm219529d1_4seq1.xml · derivative · entry 2 SHELTON JERRELL · CIK 0001283212 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,000 Underlying: Common Stock · 33,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F3 · derivative.exercise_date: The restricted stock rights vest in four equal annual installments beginning 3/9/2022. F3 · derivative.expiration_date: The restricted stock rights vest in four equal annual installments beginning 3/9/2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.